Description
KB-0742 is a selective CDK9 inhibitor with potent anti-tumor activity in castration-resistant prostate cancer models.
| Product Unit Size | Cost | Quantity | Stock |
|---|
KB-0742 is a selective CDK9 inhibitor with potent anti-tumor activity in castration-resistant prostate cancer models.
| Cas No. | 2170137-61-6 (free base) |
|---|---|
| Purity | ≥98% |
| Formula | C16H25N5 |
| Formula Wt. | 287.41 |
| IUPAC Name | (1S,3S)-3-N-(5-pentan-3-ylpyrazolo[1,5-a]pyrimidin-7-yl)cyclopentane-1,3-diamine |
| Synonym | KB0742, NSC-834161, NSC834161 |
| Appearance | Yellow to brown crystal |
| Store Temp | -20°C |
|---|---|
| Ship Temp | Ambient |
| Info Sheet |
|---|
Richters A, Doyle S, Freeman D, et al. Modulating androgen receptor-driven transcription in prostate cancer with selective CDK9 inhibitors. Cell Chem Biol. 2021 Feb 18;28(2):134-147. PMID: 33086052
Synthetic compound related to sulforaphane.
Peptide; PAR1 agonist.
ACE inhibitor.
HIV integrase inhibitor.
Nucleoside (guanosine) analog; DNA chain termin...
Synthetic nitrile compound
FAAH inhibitor.
Mycotoxin that has structural similarity to est...
Anthraquinone found in aloe; CTFR Cl- channel a...
Endogenous vitamin D prodrug.
SK K+ channel blocker, EGFR inhibitor.
CDK1/2 inhibitor.
Iron chelator.
Chalcone kavalactone found in Piper methysticum...
H+/K+ ATPase and ROCK-2 inhibitor.
p110α PI3K inhibitor.
Peptide fragment
PI3K inhibitor, microtubule polymerization inhi...
Endogenous pyrimidine base required for product...
MGMT inhibitor.